Literature DB >> 16806749

Ovarian steroids and the human breast: regulation of stem cells and cell proliferation.

Robert B Clarke1.   

Abstract

Ovarian steroidal control of mammary gland proliferation and differentiation is not well defined in the human. We therefore developed the athymic nude mouse model in which intact normal human breast tissue is xenografted subcutaneously and treated with human physiological serum levels of oestrogen (E) and/or progesterone (P). We showed that: (i) E, and not P, is the major steroid hormone inducing proliferation of epithelial cells in the adult non-pregnant, non-lactating breast; (ii) E induces progesterone receptor (PR) expression; and (iii) PR expression is maximally induced at low E concentrations while a higher amount of E was required to induce proliferation. Using double label immuno-fluorescence, we demonstrated that cells expressing the oestrogen receptor-alpha (ER alpha) invariably contained the PR but that steroid receptor expression and cell proliferation (Ki67 antigen) were dissociated. Recently, we have demonstrated that some ER alpha/PR-positive epithelial cells are quiescent breast stem cells suggesting that they act as "steroid hormone sensors" that secrete paracrine factors to regulate the proliferative activity of adjacent ER alpha/PR-negative epithelial cells. The dissociation between steroid receptor expression and cell proliferation in normal epithelium was lost at an early stage in ER alpha/PR-positive breast tumour formation perhaps indicating that they arise from deregulation of the normally quiescent breast stem cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806749     DOI: 10.1016/j.maturitas.2006.06.002

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  12 in total

1.  Death receptor 5 and neuroproliferation.

Authors:  Yanli Niu; Yongqiang Li; Jianfeng Zang; Hongen Huang; Jiexin Deng; Zhanjun Cui; Dongming Yu; Jinbo Deng
Journal:  Cell Mol Neurobiol       Date:  2011-09-22       Impact factor: 5.046

2.  Breast cancer risk in atomic bomb survivors from multi-model inference with incidence data 1958-1998.

Authors:  J C Kaiser; P Jacob; R Meckbach; H M Cullings
Journal:  Radiat Environ Biophys       Date:  2011-09-23       Impact factor: 1.925

Review 3.  Challenges in the gynecologic care of premenopausal women with breast cancer.

Authors:  Jamie N Bakkum-Gamez; Shannon K Laughlin; Jani R Jensen; Clement O Akogyeram; Sandhya Pruthi
Journal:  Mayo Clin Proc       Date:  2011-02-09       Impact factor: 7.616

4.  Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells.

Authors:  Xue-Yuan Dong; Peng Guo; Xiaodong Sun; Qunna Li; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

5.  Mapping mammary gland architecture using multi-scale in situ analysis.

Authors:  Rodrigo Fernandez-Gonzalez; Irineu Illa-Bochaca; Bryan E Welm; Markus C Fleisch; Zena Werb; Carlos Ortiz-de-Solorzano; Mary Helen Barcellos-Hoff
Journal:  Integr Biol (Camb)       Date:  2008-12-05       Impact factor: 2.192

Review 6.  Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy.

Authors:  Lisa M Arendt; Charlotte Kuperwasser
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-19       Impact factor: 2.673

7.  Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells.

Authors:  Millie A Behera; Qunsheng Dai; Rachana Garde; Carrie Saner; Emily Jungheim; Thomas M Price
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-18       Impact factor: 4.310

8.  Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis.

Authors:  Kathryn B Horwitz; Carol A Sartorius
Journal:  J Clin Endocrinol Metab       Date:  2008-07-22       Impact factor: 5.958

9.  Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.

Authors:  Kathryn B Horwitz; Wendy W Dye; Joshua Chuck Harrell; Peter Kabos; Carol A Sartorius
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

10.  Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.

Authors:  Agnès Fournier; Alban Fabre; Sylvie Mesrine; Marie-Christine Boutron-Ruault; Franco Berrino; Françoise Clavel-Chapelon
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.